ARCHIVES

NCI Director To Decide Fate Of P-4 After NCAB Meeting In June.

This article is from The Cancer Letter archive.

Vol. 33 No. 15 | April 20, 2007

Download PDF Visit The Full Archive

Related Articles

Opioid Pain Reliever Approved With Risk Reduction Plan

July 31, 2009

Senate Gives NIH Director Authority To Permit Research By Unconventional MDs

September 25, 1992

The Tivozanib Timeline

May 10, 2013

Final Regulations For Clinical Cancer Education Program Adopted

October 3, 1975

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

July 4, 1997

RFAs: Patient Outcomes “5-A-Day” Program

April 10, 1992